Nutromics, a wearable diagnostic platform, raised $14 million in funding from Dexcom Ventures, VU Venture Partners, and Artesian Investments.
The medical technology startup plans to use the fresh funds to expand across Australia and the United States.
“With this strategic industry and VC investment in us, we see more confidence in our technology and hope to accelerate our growth, as the need for our platform in the lab diagnostic space is urgent”, said Nutromics’ co-founder and CEO Peter Vranes. We aim to cause a paradigm shift in diagnostic healthcare by developing a lab-on-a-patch. A lack of timely and continuous diagnostic insights can strongly impact outcomes when dealing with critical disease states.”
Nutromics is developing a connected wearable (patch) diagnostic system that uses DNA technology to enable the tracking of multiple targets in the human body using a single patch. The sensor-powered technology will provide clinicians and patients with continuous and real-time diagnostic information ranging from hard-to-dose drugs, like vancomycin, to biological markers for conditions such as kidney disease.
Nutromics, founded in 2017, has raised a total of over $20 million to date. The company said that this latest funding would also support an expansion of clinical studies and R&D. ...